| 摘要 |
<p>A method for administering a ranolazine dosage formulations to treat patients suffering from angina who are also suffering from a second complication or disease such a heart disease and diabetes and also to reduce myocardial infarct size wherein the infarcts is the result of an ischemic event.</p> |
